To live and die in the LA (lung airway): Mode of neutrophil death and progression of chronic obstructive pulmonary disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 37, Issue 2, 2007, Pages 129-130

  Minematsu, Naoto ^a,b   Shapiro, Steven D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; GELATINASE B; HERMES ANTIGEN; INTERLEUKIN 10; LEUKOCYTE ELASTASE; MACROPHAGE ELASTASE; PHOSPHATIDYLSERINE; TRANSFORMING GROWTH FACTOR BETA;

BACTERIAL INFECTION; CELL DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; EDITORIAL; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR MATRIX; HAEMOPHILUS INFLUENZAE; HUMAN; NEUTROPHIL; PATHOGENESIS;

CELL DEATH; DISEASE PROGRESSION; HAEMOPHILUS INFECTIONS; HUMANS; LEUKOCYTE ELASTASE; LUNG; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 34547897717     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2007-0002ED     Document Type: Editorial

References (19)

1. Owen C, Campbell M, Sannes P, Boukedes S, Campbell E. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J Cell Biol 1995;13:775-789.
2. Teder P, Vandivier WR, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW. Resolution of lung inflammation by CD44. Science 2002;296:155-158.
3. Kirkham PA, Spooner G, Rahman I, Rossi AG. Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxzidation products. Biochem Biophys Res Commun 2004;318:32-37.
4. Kotani N, Kushikata T, Hashimoto H, Sessler DI, Muraoka M, Matsuki A. Recovery of intraoperative microbicidal and inflammatory functions of alveolar immune cells after a tobacco smoke-free period. Anesthesiology 2001;94:999-1006.
5. Hodge S, Hodge G, Scicchitano R, Reynolds P, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability top phagocytose apoptotic airway epithelial cells. Immonol Cell Biol 2003;81:289-296.
6. Prieto A, Reyes E, Bernstein ED, Martinez B, Monserrat J, Izquierdo JL, Callol L, de Lucas P, Alvarez-Sala R, Alvarez-Sala JL, et al. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophopeptical (immunoferon). Am J Respir Crit Care Med 2001;163:1578-1583.
7. Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoplotic cells removal (efferocytosis) on chronic inflammatory lung disease. Chest 2006;129:1673-1682.
8. Grimsley C, Ravichandran KS. Cues for apoptotic cell engulfment: eat-me, don't eat-me and come-get-me signals. Trends Cell Biol 2003;13: 648-656.
9. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophage that have ingested apoptotic cells in vitro inhibit proinflammtory cytokine production though autocrine/paracrine mechanisms involving TGF-β, PGE, and PAF. J Clin Invest 1998;101: 890-898.
10. Huynh MN, Fadok VA, Henson PM. Phosphatidylserine-dependent ingestion of apoplotic cells promotes TGF-β secretion and the resolution of inflammation. J Clin Invest 2002;109:41-50.
11. Odaka C, Mizuochi T, Yang Jingxuan Y, Ding A. Murine macrophages produce secretory leukocyte protease inhibitor during of apoptotic cells: implications for resolution of the inflammatory response. J Immunol 2003;171:1507-1514.
12. Morimoto K, Amano H, Sonoda F, Baba M, Senba M, Yoshimine H, Yamamoto H, Ii T, Oishi K, Nagatake T. Alveolar macrophage that phagocytose apoptotic neutrophils produce hepalocyte growth factor during bacterial pneumonia in mice. Am J Respir Cell Mol Biol 2001;24: 608-615.
13. Golpon HA, Fadok VA, Taraseviciene-Stewart L, Scerbavicius R, Sauer C, Welte T, Henson PM, Voelkel NF. Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth. FASEB J 2004;18:1716-1718.
14. Droemann D, Aries SP, Hansen F, Moellers M, Braun J, Katsu HA, Dalhoff K. Decreased apoptosis and increased activation of alveolar neutrophils in bacterial pneumonia. Chest 2000;117:1679-1684.
15. Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, Henson PM. Elastase-mediated phosphatidylserine receptor cleavage impaires apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 2002;109:661-670.
16. Honda Y, Takahashi H, Kuroki Y. Decreased contents of surfactant proteins A and D in BAL fluid in healthy smokers. Chest 1996;109: 1006-1009.
17. Morimoto K, Janssen WJ, Fessler MB, McPillips KA, Borges VM, Bowler RP, Xiao YQ, Kench JA, Henson PM, Vandivier RW. Lovastatinenhances clearanceof apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol 2006;176:7657-7665.
18. Yamaryo T, Ohishi K, Yoshimine H, Tsuchihashi Y, Matsushima K, Nagatake T. Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother 2003;47:48-53.
19. Wilkinson TM, Donaldson GC, Johnston SL, Openshaw PJ, Wedzicha JA. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:871-876.